Shirin Tavakoli
2PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Jul 10, 2025
Safety and Feasibility of Blockade of NK Group-2 Member-A Receptor in Natural Killer Cells Combined with Cetuximab Antibody in Patients with Advanced Gastric Adenocarcinoma.Maryam Samareh-Salavatipour, Shirin Tavakoli, Maryam Barkhordar
|Apr 07, 2025
Cell Therapy Using Anti-NKG2A Pretreated Natural Killer Cells in Patients with Hepatocellular Carcinoma.Shirin Tavakoli, Maryam Samareh-Salavati, Shahrokh Abdolahi
Pageof 1
